Rapid Bio has taken part in the 7th National Forum of Laboratory Medicine of Kazakhstan, Natforlab 2025, held in Astana on 19–20 September. The event is one of the country’s largest platforms for laboratory medicine, bringing together leading specialists and experts to exchange experience and showcase technologies shaping the future of diagnostics.
At its stand, Rapid Bio presented a range of rapid test systems covering key public health priorities, including:
The company’s point-of-care solutions are designed to deliver fast and reliable results directly at the site of care, improving access to diagnostics and supporting higher quality of medical services.
Alongside the exhibition programme, Rapid Bio held a series of B2B meetings to outline its strategic plans for partnerships and product promotion. These talks are seen as an important step towards strengthening cooperation and expanding the company’s footprint in the Central Asian market.
The company says participation in major industry platforms such as Natforlab 2025 helps bring modern diagnostics closer to patients while setting new directions for the development of laboratory medicine across the region.
At its stand, Rapid Bio presented a range of rapid test systems covering key public health priorities, including:
- third- and fourth-generation HIV diagnostics;
- rapid solutions for detecting influenza and COVID-19;
- tests for viral hepatitis B and C.
The company’s point-of-care solutions are designed to deliver fast and reliable results directly at the site of care, improving access to diagnostics and supporting higher quality of medical services.
Alongside the exhibition programme, Rapid Bio held a series of B2B meetings to outline its strategic plans for partnerships and product promotion. These talks are seen as an important step towards strengthening cooperation and expanding the company’s footprint in the Central Asian market.
The company says participation in major industry platforms such as Natforlab 2025 helps bring modern diagnostics closer to patients while setting new directions for the development of laboratory medicine across the region.